Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early experience with robotic aortic valve replacement.

Thierry A Folliguet1, Fabrice Vanhuyse, Zanis Konstantinos

  • 1Department of cardiovascular surgery, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, F-75014 Paris, France. thierry.folliguet@imm.fr

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|June 29, 2005
PubMed
Summary

Robotic aortic valve replacement using the da Vinci system is feasible. This initial experience showed no major complications, demonstrating the potential of minimally invasive robotic surgery for aortic valve procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Congenital absence of the left pericardium presenting as cardiogenic shock: a case report.

European heart journal. Case reports·2026
Same author

Early impact of CytoSorb® adsorber on proinflammatory cytokine plasmatic levels in a porcine model of refractory cardiogenic shock supported with VA-ECMO.

BMC cardiovascular disorders·2025
Same author

Follow-Up of Left-Ventricular Assist Device Patients With Telemonitoring: A National Retrospective Multicentric Study on the Satelia LVAD Web Application.

Artificial organs·2025
Same author

Epicardial and hybrid surgical ablation of atrial fibrillation: 1-year follow-up outcomes of the EORP EHAFA registry.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

A presentation of posterior reversible encephalopathy syndrome after heart transplantation: a case report and review of literature.

Journal of medical case reports·2025
Same author

Right Ventriculoarterial Coupling Surrogates and Long-Term Survival in LVAD Recipients: Results of the ASSIST-ICD Multicentric Registry.

Journal of cardiac failure·2024

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Aortic valve replacement is a common cardiac procedure.
  • Minimally invasive techniques are increasingly explored to reduce surgical trauma.
  • Robotic assistance offers potential advantages in precision and visualization for complex surgeries.

Purpose of the Study:

  • To report the initial experience and outcomes of aortic valve replacement (AVR) performed with robotic assistance.
  • To evaluate the safety and feasibility of the da Vinci robotic system for AVR.

Main Methods:

  • Five patients underwent robotic AVR between February and September 2004.
  • Procedures utilized peripheral cardiopulmonary bypass, transthoracic aortic cross-clamp, and antegrade cold crystalloid cardioplegia.

Related Experiment Videos

  • Access was achieved through one or two ports and a small (5-cm) intercostal incision.

    • Main Results:

    • All five patients successfully underwent robotic AVR without incisional conversion.
    • No deaths, strokes, or reoperations for bleeding occurred.
    • Mean procedure time was 231.2 minutes, cardiopulmonary bypass time was 121.5 minutes, and cross-clamp time was 98.2 minutes.
    • One patient developed postoperative pneumonia.

    Conclusions:

    • Robotic-assisted aortic valve replacement is a safe and feasible option.
    • The da Vinci robotic system can be successfully employed for AVR.
    • This approach may offer a minimally invasive alternative for patients requiring aortic valve surgery.